Phathom Pharmaceuticals, Inc. (PHAT)
10.96
+0.29
(+2.72%)
USD |
NASDAQ |
Mar 09, 14:02
Phathom Pharmaceuticals SG&A Expense (TTM) : 279.72M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| MannKind Corp. | 229.86M |
| Vanda Pharmaceuticals, Inc. | 237.95M |
| Ligand Pharmaceuticals, Inc. | 92.45M |
| Ocugen, Inc. | 21.45M |
| Rhythm Pharmaceuticals, Inc. | 194.94M |